Status:
COMPLETED
Sedation Using Intranasal Dexmedetomidine in Upper Gastrointestinal Endoscopy
Lead Sponsor:
The University of Hong Kong
Conditions:
Gastrointestinal Disease
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
Upper gastrointestinal endoscopy, like many other diagnostic and therapeutic procedures, may be associated with discomfort. Although upper endoscopy is usually of shorter duration and better tolerated...
Detailed Description
Aims: This study aims to evaluate sedative effects using intranasal dexmedetomidine in upper gastrointestinal endoscopy. The investigators aim to evaluate the efficacy, side effects and acceptability...
Eligibility Criteria
Inclusion
- American Society of Anesthesiology grade I-III
- 18-60 years old
- Patients having upper endoscopy
Exclusion
- Clinical history or electrocardiographic evidence of heart block, ischaemic - heart disease, asthma, sleep apnoea syndrome
- BMI \> 35kg/m2
- Impaired liver (preoperative serum albumin level less than 30g/L ) or renal function (creatinine \>120umol/L)) or known renal or hepatic disease
- Alcohol consumption in excess of 28 units per week
- Pregnancy
- Patient refusal
- Known psychiatric illness
- Chronic sedative use, and regular use of or known allergy to dexmedetomidine, propofol and opioids.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01887184
Start Date
January 1 2009
End Date
April 1 2010
Last Update
July 11 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.